Neuphoria Therapeutics Inc (NEUP)

Finanzdaten der Neuphoria Therapeutics Inc-Aktie (NEUP)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Operating Expenses	452.97%6.70	1.21	4.06	5.65	5.82
Depreciation and Amortization	0.17	-	0.17	0.17	0.17
Operating Income/Loss	356.07%-5.53	-1.21	-4.06	-5.65	-5.84
Nonoperating Income/Loss	12.67%0.59	0.67	5.89	-4.29	-3.32
Income/Loss From Continuing Operations Before Tax	814.92%-4.94	-0.54	1.83	-9.94	-9.15
Income Tax Expense/Benefit	-0.03	-0.03	-0.03	-0.03	-0.27
	871.06%-4.90	-0.51	1.86	-9.91	-8.88
Attributable To Parent	871.06%-4.90	-0.51	1.86	-9.91	-8.88